3 Polish doctors convicted in 2021 death of pregnant woman
The death from sepsis of the woman known as Iza at a hospital in southern Poland in her 22nd week of pregnancy led to huge street protests against the country's restrictive anti-abortion law. Activists blamed her death on doctors' choice to 'wait and see' rather than immediately carry out an abortion because of the Poland's near-ban on the procedure.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
20 minutes ago
- Winnipeg Free Press
Billy Joel says he's ‘OK' and not ‘deathly ill' after receiving brain disorder diagnosis
NEW YORK (AP) — Billy Joel is doing much better, the 'Piano Man' singer wants fans to know. In May, Joel canceled all his upcoming concerts across North America and England after being diagnosed with fluid buildup in his brain that has affected his 'hearing, vision and balance.' The condition is called Normal Pressure Hydrocephalus, 'a brain disorder that can affect brain-related abilities, including thinking and concentrating, memory, movement and more,' the Cleveland Clinic says. 'I know a lot of people are worried about me and my health, but I'm OK,' Joel said in an interview with People magazine. 'What I have is something very few people know about, including me, no matter how much you try to research it. I'm doing my best to work with it and to recover from it.' 'It was scary, but I'm OK,' Joel, 76, says. 'I just wanted to let people know, don't worry about me being deathly ill or anything.' He also discussed his health in an episode of comedian Bill Maher's Club Random podcast, telling the host he feels 'fine,' adding that, 'My balance sucks. It's like being on a boat… They keep referring to what I have as a brain disorder, so it sounds a lot worse than what I'm feeling.' He added that his health issues are not 'fixed,' but 'it's still being worked on.' A representative for Joel declined additional comment. In March, the 'Uptown Girl' singer announced that he underwent surgery and had to undergo physical therapy. A statement at the time said doctors expected him to make a full recovery. It is unclear if his medical issues at the time were related to Normal Pressure Hydrocephalus. The condition can cause problems with walking, bladder control and thinking, with symptoms worsening if left untreated. It's relatively rare and can be hard to diagnose. It can be treated successfully with surgery to install a tube to drain excess fluid. Patients may need physical therapy in addition to surgery.
Winnipeg Free Press
an hour ago
- Winnipeg Free Press
Paul Gascoigne ‘back home and doing well' after hospital visit, representative says
LONDON (AP) — Former England midfielder Paul Gascoigne is back home and 'doing well' after being hospitalized over the weekend, his representative said Monday. 'Paul voluntarily went into A&E on Friday after struggling with a throat condition he has had for a while,' Carly Saward at The MNT talent agency told The Associated Press in an email. 'He is already back home and doing well.' British newspaper The Sun reported that the 58-year-old Gascoigne had been found 'semi-conscious' at home by a friend on Friday in Poole in south England and initially been admitted to an intensive care unit. Gascoigne helped lead England to the semifinals at the 1990 World Cup and 1996 European Championship and was widely considered one of the most naturally talented players of his generation. But he has battled alcohol addiction for decades and has also had other health problems in recent years. Thursdays Keep up to date on sports with Mike McIntyre's weekly newsletter. ___ AP soccer:
Winnipeg Free Press
5 hours ago
- Winnipeg Free Press
FDA names former pharmaceutical company executive to oversee US drug program
WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency. FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs. His appointment comes a month after the center's acting director, Dr. Jacqueline Corrigan-Curay, announced her retirement. As the agency's top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Makary and his boss, Health Secretary Robert F. Kennedy Jr., including reviewing the safety of the abortion pill mifepristone. The FDA is also scrutinizing certain uses of other long-established drugs, including antidepressants and hormone-replacement drugs for menopause. Tidmarsh founded and led several pharmaceutical companies, including Horizon Pharmaceuticals, maker of an anti-inflammatory medication for arthritis. He has also served as an adjunct professor at Stanford University. The FDA's drug center is the agency's largest unit, with nearly 6,000 staffers responsible for reviewing the safety and effectiveness of new drugs and monitoring the use and marketing of older drugs. About 2,000 FDA staffers have been laid off as part of widescale cuts to the federal health workforce overseen by Kennedy. More than 1,000 others have taken buyouts or early retirement, while many others are reportedly searching for new jobs. The departures have threatened basic FDA operations, including the timely review of new drugs. FDA's drug center hasn't had a permanent director since January, when Dr. Patrizia Cavazzoni stepped down days before President Donald Trump took office. Nearly all of the FDA's senior leadership positions have turned over in recent months, either due to retirements, resignations or actions by administration officials placing them on administrative leave. FDA center directors typically hold their positions for years or even decades, serving across multiple administrations, whether Republican or Democrat. In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA's COVID response, to run the agency's vaccine center. He was also named to the post of FDA chief medical officer. Prasad joined the agency after his predecessor, longtime vaccine chief Dr. Peter Marks, was forced out in March. The head of FDA's tobacco center was also forced to step down in April. A permanent replacement has not yet been named. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
